Wantai
Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines
Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines, with the concept of "science-based, health-conscious", the aim of "quality for survival, scientific and technological innovation for development", and the pursuit of "to contribute to the cause of human health", to transform the achievements of biological technology into high-quality products to serve the public.
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ForLong Biotech Nets Over CNY 100 Mn in Series A
CytoCan Corp. Nets CNY 10 Mn in Seed Round
Levostar Completes Pre-A Financing Round to Further Invest in CGT
BlissBio Nets Over CNY 100 Mn in Series B+
Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round
NaviSeed Nets Tens of millions of CNY in Angel Round
Nuwacell Nets Hundreds of Mns of CNY in Series A
Enitiatebio Nets One Hundred Million of CNY in Series A Round
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%